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Study selection and assessment: an expert panel of rheumatologists reached a consensus on 10 key evidence-based recommendations for the diagnosis of gout using the Delphi technique. Studies assessing these recommendations and the clinical diagnosis of gout or hyperuricaemia, if serum uric acid was measured as a risk factor for gout, were included. Case reports, review articles, editorials, commentaries, and studies on animals or healthy individuals were excluded. Quality assessment of individual studies was based on study design.
Outcomes: sensitivity, specificity, and likelihood ratio (LR).
MAIN RESULTS
181 studies met the selection criteria: 83 for diagnosis, 86 for management, and 12 for both; 3 case control studies were used or combined for the diagnostic test 
Commentary
G out is a rarity in rheumatology-a curable disease. The struggle, however, is getting primary practitioners the tools to diagnose and appropriately treat the condition. A first step is to establish expert recommendations from the rheumatological community. At a time when strong evidence bases exist for many diseases, it is noteworthy that a paucity of evidence exists for gout.
In the review by Zhang et al, these issues were addressed by a team of European clinician-scientists, using a clever combination of existing literature and structured expert opinion to construct the first set of guidelines for the diagnosis of gout since 1977. Given the absence of meta-analyses for individual features, the group used a combination of LRs and an expert grading system to make its recommendations.
Although the methodology was sound, several issues should be noted. Firstly, the gold standard for the LRs was the clinical diagnosis of gout, a bit of a tautology when the predictive factors included the clinical features. Secondly, there was mention of statistical pooling of data, but the methods are not detailed. Thirdly, it is uncertain from 2 of the studies cited and the experts chosen whether the experiences of full time clinicians and community patients were included.
With these caveats, however, primary care clinicians should note that the strongest recommendations from the panel based on both perceived strength of evidence and likelihood ratios were the following: (1) While MSU crystals are definitive, hyperuricaemia and podagra provide a reasonably accurate diagnosis. (2) Hyperuricaemia alone is not diagnostic. (3) Radiographs and renal uric acid are not diagnostic. (4) Risk factors such as obesity and hypertension should be identified.
Of most practical importance to busy primary clinicians is that a patient with a rapidly swollen, red big toe with hyperuricaemia has a high probability of acute gout. Using this rule, physicians should be able to easily diagnose gout and begin acute or chronic therapy.
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